Product Code: PMRREP12874
Veterinary Molecular Diagnostics Market: Scope of the Report
The latest publication by Persistence Market Research on the global veterinary molecular diagnostics market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023 - 2033.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for veterinary molecular diagnostics market products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the veterinary molecular diagnostics market. Shareholders in the veterinary molecular diagnostics market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.
Market statistics, as well as information linked to the macro as well as microeconomic variables affecting the business scenario in the veterinary molecular diagnostics market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research's study on the veterinary molecular diagnostics market offers information divided into five important segments - product, disease, species, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
PCR Kits
RT-PCR Kits
RAPD-PCR Kits
INAAT Kits
Microarray Kits
DNA Sequencing Kits
Disease
Anaplasma spp.
Ehrlichia spp.
New Castle Disease
Influenza
Porcine Reproductive & Respiratory Syndrome (PRRS)
Others
Species
Livestock Animals
Equine
Porcine
Poultry
Bovine/Cattle
Aquatic
Ovine
Companion Animals
Canine
Feline
Avian
End User
Veterinary Hospitals
Clinical Laboratories
Veterinary Research Institutes
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Key Questions Answered in Report:
Which regions will continue to remain the most profitable regional markets for veterinary molecular diagnostics market players?
Which factors will induce a change in the demand for veterinary molecular diagnostics in the assessment period?
How will changing trends influence the veterinary molecular diagnostics market?
How can market players capture the low-hanging opportunities in the veterinary molecular diagnostics in developed regions?
What are the winning strategies of stakeholders in the veterinary molecular diagnostics market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and might tackle while investing in the veterinary molecular diagnostics market?
What are the developmental trends in veterinary molecular diagnostics sectors that will influence the market?
How businesses in the veterinary molecular diagnostics market can avail growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the veterinary molecular diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the veterinary molecular diagnostics market are more accurate and reliable.
Table of Contents
1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand Side Trends
- 1.3. Supply Side Trends
- 1.4. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 2.3. Inclusions and Exclusions
3. Key Market Trends
- 3.1. Key Trends Impacting the Market
- 3.2. Market Innovation / Development Trends
4. Key Success Factors
- 4.1. Key Promotional Strategies, by Manufacturers
- 4.2. Key Regulations
- 4.3. PESTEL Analysis
- 4.4. Porter's Analysis
- 4.5. Product Launch Activities
- 4.6. Product Adoption/Usage Analysis
- 4.7. Product USPs/ Features
- 4.8. Production Analysis by Region
- 4.9. Reimbursement Scenario
- 4.10. Trade Analysis
- 4.11. Value Chain Analysis
5. Market Background
- 5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Outlook
- 5.1.3. Global Veterinary Diagnostics Market Outlook
- 5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Increasing Strategic Collaborations Among Key Players
- 5.2.2. Rise in Awareness About Diseases in Animals Worldwide
- 5.2.3. High Adoption of Molecular Diagnostic Kits for Veterinary Diseases
- 5.2.4. Higher Prevalence of Chronic & Infectious Diseases in Animals
- 5.2.5. Advancements in Molecular Technology
- 5.2.6. Growing Acceptance of Advanced Molecular Diagnostic Techniques
- 5.2.7. Ease in FDA Clearance for Veterinary Products
- 5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
- 6.1. COVID-19 and Impact Analysis
- 6.1.1. By Product
- 6.1.2. By Disease
- 6.1.3. By Species
- 6.1.4. By End User
- 6.1.5. By Country
- 6.2. 2022 Market Scenario
7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2015-2022 and Forecast, 2023-2033
- 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2022
- 7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Product
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Mn) Analysis by Product, 2015-2022
- 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product, 2023-2033
- 8.3.1. PCR Kits
- 8.3.1.1. RT-PCR Kits
- 8.3.1.2. RAPD-PCR Kits
- 8.3.2. INAAT Kits
- 8.3.3. Microarray Kits
- 8.3.4. DNA Sequencing Kits
- 8.4. Market Attractiveness Analysis by Product
9. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Disease
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Mn) Analysis by Disease, 2015-2022
- 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Disease, 2023-2033
- 9.3.1. Anaplasma spp.
- 9.3.2. Ehrlichia spp.
- 9.3.3. New Castle Disease
- 9.3.4. Influenza
- 9.3.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
- 9.3.6. Others
- 9.4. Market Attractiveness Analysis by Disease
10. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Species
- 10.1. Introduction / Key Findings
- 10.2. Historical Market Size (US$ Mn) Analysis by Species, 2015-2022
- 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Species, 2023-2033
- 10.3.1. Livestock Animals
- 10.3.1.1. Porcine
- 10.3.1.2. Poultry
- 10.3.1.3. Bovine/Cattle
- 10.3.1.4. Aquatic
- 10.3.1.5. Ovine
- 10.3.2. Companion Animals
- 10.3.2.1. Canine
- 10.3.2.2. Feline
- 10.3.2.3. Avian
- 10.4. Market Attractiveness Analysis by Species
11. Global Market Analysis 2015-2022 and Forecast 2023-2033, By End User
- 11.1. Introduction / Key Findings
- 11.2. Historical Market Size (US$ Mn) Analysis by End User, 2015-2022
- 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2023-2033
- 11.3.1. Veterinary Hospitals
- 11.3.2. Clinical Laboratories
- 11.3.3. Veterinary Research Institutes
- 11.4. Market Attractiveness Analysis by End User
12. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Region
- 12.1. Introduction / Key Findings
- 12.2. Historical Market Size (US$ Mn) Analysis, by Region, 2015-2022
- 12.3. Current and Future Market Size (US$ Mn) Analysis Forecast by Region, 2023-2033
- 12.3.1. North America
- 12.3.2. Latin America
- 12.3.3. Europe
- 12.3.4. East Asia
- 12.3.5. South Asia
- 12.3.6. Oceania
- 12.3.7. Middle East & Africa
- 12.4. Market Attractiveness Analysis by Region
13. North America Market Analysis 2015-2022 and Forecast 2023-2033
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2015-2022
- 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
- 13.3.1. By Country
- 13.3.1.1. U.S.
- 13.3.1.2. Canada
- 13.3.2. By Product
- 13.3.3. By Disease
- 13.3.4. By Species
- 13.3.5. By End User
- 13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Product
- 13.4.3. By Disease
- 13.4.4. By Species
- 13.4.5. By End User
- 13.5. Market Trends
- 13.6. Key Market Participants - Intensity Mapping
- 13.7. Drivers and Restraints - Impact Analysis
- 13.8. Country Level Analysis & Forecast
- 13.8.1. U.S. Market
- 13.8.1.1. Introduction
- 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.1.2.1. By Product
- 13.8.1.2.2. By Disease
- 13.8.1.2.3. By Species
- 13.8.1.2.4. By End User
- 13.8.2. Canada Market
- 13.8.2.1. Introduction
- 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.2.2.1. By Product
- 13.8.2.2.2. By Disease
- 13.8.2.2.3. By Species
- 13.8.2.2.4. By End User
14. Latin America Market Analysis 2015-2022 and Forecast 2023-2033
- 14.1. Introduction
- 14.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2015-2022
- 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
- 14.3.1. By Country
- 14.3.1.1. Mexico
- 14.3.1.2. Brazil
- 14.3.1.3. Argentina
- 14.3.1.4. Rest of Latin America
- 14.3.2. By Product
- 14.3.3. By Disease
- 14.3.4. By Species
- 14.3.5. By End User
- 14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product
- 14.4.3. By Disease
- 14.4.4. By Species
- 14.4.5. By End User
- 14.5. Market Trends
- 14.6. Key Market Participants - Intensity Mapping
- 14.7. Drivers and Restraints - Impact Analysis
- 14.8. Country Level Analysis & Forecast
- 14.8.1. Mexico Market Analysis
- 14.8.1.1. Introduction
- 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.1.2.1. By Product
- 14.8.1.2.2. By Disease
- 14.8.1.2.3. By Species
- 14.8.1.2.4. By End User
- 14.8.2. Brazil Market Analysis
- 14.8.2.1. Introduction
- 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.2.2.1. By Product
- 14.8.2.2.2. By Disease
- 14.8.2.2.3. By Species
- 14.8.2.2.4. By End User
- 14.8.3. Argentina Market Analysis
- 14.8.3.1. Introduction
- 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.3.2.1. By Product
- 14.8.3.2.2. By Disease
- 14.8.3.2.3. By Species
- 14.8.3.2.4. By End User
15. Europe Market Analysis 2015-2022 and Forecast 2023-2033
- 15.1. Introduction
- 15.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2015-2022
- 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
- 15.3.1. By Country
- 15.3.1.1. Germany
- 15.3.1.2. Italy
- 15.3.1.3. France
- 15.3.1.4. U.K.
- 15.3.1.5. Spain
- 15.3.1.6. BENELUX
- 15.3.1.7. Russia
- 15.3.1.8. Rest of Europe
- 15.3.2. By Product
- 15.3.3. By Disease
- 15.3.4. By Species
- 15.3.5. By End User
- 15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product
- 15.4.3. By Disease
- 15.4.4. By Species
- 15.4.5. By End User
- 15.5. Market Trends
- 15.6. Key Market Participants - Intensity Mapping
- 15.7. Drivers and Restraints - Impact Analysis
- 15.8. Country Level Analysis & Forecast
- 15.8.1. Germany Market Analysis
- 15.8.1.1. Introduction
- 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.1.2.1. By Product
- 15.8.1.2.2. By Disease
- 15.8.1.2.3. By Species
- 15.8.1.2.4. By End User
- 15.8.2. Italy Market Analysis
- 15.8.2.1. Introduction
- 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.2.2.1. By Product
- 15.8.2.2.2. By Disease
- 15.8.2.2.3. By Species
- 15.8.2.2.4. By End User
- 15.8.3. France Market Analysis
- 15.8.3.1. Introduction
- 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.3.2.1. By Product
- 15.8.3.2.2. By Disease
- 15.8.3.2.3. By Species
- 15.8.3.2.4. By End User
- 15.8.4. U.K. Market Analysis
- 15.8.4.1. Introduction
- 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.4.2.1. By Product
- 15.8.4.2.2. By Disease
- 15.8.4.2.3. By Species
- 15.8.4.2.4. By End User
- 15.8.5. Spain Market Analysis
- 15.8.5.1. Introduction
- 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.5.2.1. By Product
- 15.8.5.2.2. By Disease
- 15.8.5.2.3. By Species
- 15.8.5.2.4. By End User
- 15.8.6. BENELUX Market Analysis
- 15.8.6.1. Introduction
- 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.6.2.1. By Product
- 15.8.6.2.2. By Disease
- 15.8.6.2.3. By Species
- 15.8.6.2.4. By End User
- 15.8.7. Russia Market Analysis
- 15.8.7.1. Introduction
- 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.7.2.1. By Product
- 15.8.7.2.2. By Disease
- 15.8.7.2.3. By Species
- 15.8.7.2.4. By End User
16. East Asia Market Analysis 2015-2022 and Forecast 2023-2033
- 16.1. Introduction
- 16.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2015-2022
- 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
- 16.3.1. By Country
- 16.3.1.1. China
- 16.3.1.2. Japan
- 16.3.1.3. South Korea
- 16.3.2. By Product
- 16.3.3. By Disease
- 16.3.4. By Species
- 16.3.5. By End User
- 16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By Disease
- 16.4.4. By Species
- 16.4.5. By End User
- 16.5. Market Trends
- 16.6. Key Market Participants - Intensity Mapping
- 16.7. Drivers and Restraints - Impact Analysis
- 16.8. Country Level Analysis & Forecast
- 16.8.1. China Market Analysis
- 16.8.1.1. Introduction
- 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.1.2.1. By Product
- 16.8.1.2.2. By Disease
- 16.8.1.2.3. By Species
- 16.8.1.2.4. By End User
- 16.8.2. Japan Market Analysis
- 16.8.2.1. Introduction
- 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.2.2.1. By Product
- 16.8.2.2.2. By Disease
- 16.8.2.2.3. By Species
- 16.8.2.2.4. By End User
- 16.8.3. South Korea Market Analysis
- 16.8.3.1. Introduction
- 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.3.2.1. By Product
- 16.8.3.2.2. By Disease
- 16.8.3.2.3. By Species
- 16.8.3.2.4. By End User
17. South Asia Market Analysis 2015-2022 and Forecast 2023-2033
- 17.1. Introduction
- 17.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2015-2022
- 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
- 17.3.1. By Country
- 17.3.1.1. India
- 17.3.1.2. Indonesia
- 17.3.1.3. Malaysia
- 17.3.1.4. Thailand
- 17.3.1.5. Rest of South Asia
- 17.3.2. By Product
- 17.3.3. By Disease
- 17.3.4. By Species
- 17.3.5. By End User
- 17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By Disease
- 17.4.4. By Species
- 17.4.5. By End User
- 17.5. Market Trends
- 17.6. Key Market Participants - Intensity Mapping
- 17.7. Drivers and Restraints - Impact Analysis
- 17.8. Country Level Analysis & Forecast
- 17.8.1. India Market Analysis
- 17.8.1.1. Introduction
- 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.1.2.1. By Product
- 17.8.1.2.2. By Disease
- 17.8.1.2.3. By Species
- 17.8.1.2.4. By End User
- 17.8.2. Indonesia Market Analysis
- 17.8.2.1. Introduction
- 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.2.2.1. By Product
- 17.8.2.2.2. By Disease
- 17.8.2.2.3. By Species
- 17.8.2.2.4. By End User
- 17.8.3. Malaysia Market Analysis
- 17.8.3.1. Introduction
- 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.3.2.1. By Product
- 17.8.3.2.2. By Disease
- 17.8.3.2.3. By Species
- 17.8.3.2.4. By End User
- 17.8.4. Thailand Market Analysis
- 17.8.4.1. Introduction
- 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.4.2.1. By Product
- 17.8.4.2.2. By Disease
- 17.8.4.2.3. By Species
- 17.8.4.2.4. By End User
18. Oceania Market Analysis 2015-2022 and Forecast 2023-2033
- 18.1. Introduction
- 18.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2015-2022
- 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
- 18.3.1. By Country
- 18.3.1.1. Australia
- 18.3.1.2. New Zealand
- 18.3.2. By Product
- 18.3.3. By Disease
- 18.3.4. By Species
- 18.3.5. By End User
- 18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Product
- 18.4.3. By Disease
- 18.4.4. By Species
- 18.4.5. By End User
- 18.5. Market Trends
- 18.6. Key Market Participants - Intensity Mapping
- 18.7. Drivers and Restraints - Impact Analysis
- 18.8. Country Level Analysis & Forecast
- 18.8.1. Australia Market Analysis
- 18.8.1.1. Introduction
- 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 18.8.1.2.1. By Product
- 18.8.1.2.2. By Disease
- 18.8.1.2.3. By Species
- 18.8.1.2.4. By End User
- 18.8.2. New Zealand Market Analysis
- 18.8.2.1. Introduction
- 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 18.8.2.2.1. By Product
- 18.8.2.2.2. By Disease
- 18.8.2.2.3. By Species
- 18.8.2.2.4. By End User
19. Middle East and Africa (MEA) Market Analysis 2015-2022 and Forecast 2023-2033
- 19.1. Introduction
- 19.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2015-2022
- 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023-2033
- 19.3.1. By Country
- 19.3.1.1. GCC Countries
- 19.3.1.2. Turkiye
- 19.3.1.3. North Africa
- 19.3.1.4. South Africa
- 19.3.1.5. Rest of Middle East and Africa
- 19.3.2. By Product
- 19.3.3. By Disease
- 19.3.4. By Species
- 19.3.5. By End User
- 19.4. Market Attractiveness Analysis
- 19.4.1. By Country
- 19.4.2. By Product
- 19.4.3. By Disease
- 19.4.4. By Species
- 19.4.5. By End User
- 19.5. Market Trends
- 19.6. Key Market Participants - Intensity Mapping
- 19.7. Drivers and Restraints - Impact Analysis
- 19.8. Country Level Analysis & Forecast
- 19.8.1. GCC Countries Market Analysis
- 19.8.1.1. Introduction
- 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 19.8.1.2.1. By Product
- 19.8.1.2.2. By Disease
- 19.8.1.2.3. By Species
- 19.8.1.2.4. By End User
- 19.8.2. Turkiye Market Analysis
- 19.8.2.1. Introduction
- 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 19.8.2.2.1. By Product
- 19.8.2.2.2. By Disease
- 19.8.2.2.3. By Species
- 19.8.2.2.4. By End User
- 19.8.3. South Africa Market Analysis
- 19.8.3.1. Introduction
- 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 19.8.3.2.1. By Product
- 19.8.3.2.2. By Disease
- 19.8.3.2.3. By Species
- 19.8.3.2.4. By End User
- 19.8.4. North Africa Market Analysis
- 19.8.4.1. Introduction
- 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 19.8.4.2.1. By Product
- 19.8.4.2.2. By Disease
- 19.8.4.2.3. By Species
- 19.8.4.2.4. By End User
20. Market Structure Analysis
- 20.1. Market Analysis by Tier of Companies
- 20.2. Market Share Analysis of Top Players
- 20.3. Market Presence Analysis
21. Competition Analysis
- 21.1. Competition Dashboard
- 21.2. Competition Benchmarking
- 21.3. Competition Deep Dive
- 21.3.1. bioMerieux SA
- 21.3.1.1. Overview
- 21.3.1.2. Product Portfolio
- 21.3.1.3. Sales Footprint
- 21.3.1.4. Key Financials
- 21.3.1.5. SWOT Analysis
- 21.3.1.6. Key Developments
- 21.3.1.7. Strategy Overview
- 21.3.1.7.1. Marketing Strategy
- 21.3.1.7.2. Product Strategy
- 21.3.1.7.3. Channel Strategy
- 21.3.2. IDEXX Laboratories, Inc.
- 21.3.2.1. Overview
- 21.3.2.2. Product Portfolio
- 21.3.2.3. Sales Footprint
- 21.3.2.4. Key Financials
- 21.3.2.5. SWOT Analysis
- 21.3.2.6. Key Developments
- 21.3.2.7. Strategy Overview
- 21.3.2.7.1. Marketing Strategy
- 21.3.2.7.2. Product Strategy
- 21.3.2.7.3. Channel Strategy
- 21.3.3. Thermo Fisher Scientific Inc.
- 21.3.3.1. Overview
- 21.3.3.2. Product Portfolio
- 21.3.3.3. Sales Footprint
- 21.3.3.4. Key Financials
- 21.3.3.5. SWOT Analysis
- 21.3.3.6. Key Developments
- 21.3.3.7. Strategy Overview
- 21.3.3.7.1. Marketing Strategy
- 21.3.3.7.2. Product Strategy
- 21.3.3.7.3. Channel Strategy
- 21.3.4. Qiagen N.V.
- 21.3.4.1. Overview
- 21.3.4.2. Product Portfolio
- 21.3.4.3. Sales Footprint
- 21.3.4.4. Key Financials
- 21.3.4.5. SWOT Analysis
- 21.3.4.6. Key Developments
- 21.3.4.7. Strategy Overview
- 21.3.4.7.1. Marketing Strategy
- 21.3.4.7.2. Product Strategy
- 21.3.4.7.3. Channel Strategy
- 21.3.5. Neogen Corporation
- 21.3.5.1. Overview
- 21.3.5.2. Product Portfolio
- 21.3.5.3. Sales Footprint
- 21.3.5.4. Key Financials
- 21.3.5.5. SWOT Analysis
- 21.3.5.6. Key Developments
- 21.3.5.7. Strategy Overview
- 21.3.5.7.1. Marketing Strategy
- 21.3.5.7.2. Product Strategy
- 21.3.5.7.3. Channel Strategy
- 21.3.6. ID. Vet
- 21.3.6.1. Overview
- 21.3.6.2. Product Portfolio
- 21.3.6.3. Sales Footprint
- 21.3.6.4. Key Financials
- 21.3.6.5. SWOT Analysis
- 21.3.6.6. Key Developments
- 21.3.6.7. Strategy Overview
- 21.3.6.7.1. Marketing Strategy
- 21.3.6.7.2. Product Strategy
- 21.3.6.7.3. Channel Strategy
- 21.3.7. INDICAL BIOSCIENCE GmbH
- 21.3.7.1. Overview
- 21.3.7.2. Product Portfolio
- 21.3.7.3. Sales Footprint
- 21.3.7.4. Key Financials
- 21.3.7.5. SWOT Analysis
- 21.3.7.6. Key Developments
- 21.3.7.7. Strategy Overview
- 21.3.7.7.1. Marketing Strategy
- 21.3.7.7.2. Product Strategy
- 21.3.7.7.3. Channel Strategy
- 21.3.8. Veterinary Molecular Diagnostics, Inc.
- 21.3.8.1. Overview
- 21.3.8.2. Product Portfolio
- 21.3.8.3. Sales Footprint
- 21.3.8.4. Key Financials
- 21.3.8.5. SWOT Analysis
- 21.3.8.6. Key Developments
- 21.3.8.7. Strategy Overview
- 21.3.8.7.1. Marketing Strategy
- 21.3.8.7.2. Product Strategy
- 21.3.8.7.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology